Therapeutic Asset Ratings
5,108 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cyclophosphamide
Lung Cancer
City of Hope Medical Center
P3
BB
(66)
Cyclophosphamide
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology Group
P3
BB
(66)
Cyclophosphamide
Cutaneous Melanoma
East Metropolitan Health Service, Australia
P3
BB
(66)
Cyclophosphamide
Chronic Progressive Multiple Sclerosis
Bruce Cree
P3
BB
(66)
Cyclophosphamide
Primary Peritoneal Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
P3
BB
(66)
Cyclophosphamide
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Nathan Denlinger
P3
BB
(66)
Cyclophosphamide
Richter Transformation
SWOG Cancer Research Network
P3
BB
(66)
Cyclophosphamide
Renal Cell Carcinoma
City of Hope Medical Center
P3
BB
(66)
Cyclophosphamide
Splenic Marginal Zone Lymphoma
SWOG Cancer Research Network
P3
BB
(66)
Cyclophosphamide
Gastric Neoplasm
National Cancer Institute (NCI)
P3
BB
(66)
CYCLOSPORIN A
Acute Lymphoblastic Leukemia
City of Hope Medical Center
P3
BB
(66)
CYCLOSPORIN A
Hematopoietic And Lymphoid Cell Neoplasm
Children's Oncology Group
P3
BB
(66)
CYTARABINE
Acute Myeloid Leukemia, FLT3 Internal Tandem Duplication
First Affiliated Hospital of Zhejiang University
P3
BB
(66)
CYTARABINE
T-Cell Adult Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BB
(66)
CYTARABINE
T Lymphoblastic Leukemia/Lymphoma
Princess Maxima Center for Pediatric Oncology
P3
BB
(66)
CYTARABINE
T-Cell Non-Hodgkin Lymphoma
St. Jude Children's Research Hospital
P3
BB
(66)
CYTARABINE
Myeloproliferative Neoplasm
Fred Hutchinson Cancer Center
P3
BB
(66)
Dabrafenib
Cutaneous Melanoma
Immuneering Corporation
P3
BB
(66)
DACARBAZINE
Hodgkin'S Lymphoma, Mixed Cellularity
National Cancer Institute (NCI)
P3
BB
(66)
DACARBAZINE
Nodular Sclerosis Classical Hodgkin Lymphoma
National Cancer Institute (NCI)
P3
BB
(66)
DACARBAZINE
Hodgkin'S Lymphoma, Lymphocytic Depletion
National Cancer Institute (NCI)
P3
BB
(66)
DACARBAZINE
Hodgkin'S Lymphoma, Lymphocytic-Histiocytic Predominance
National Cancer Institute (NCI)
P3
BB
(66)
DACARBAZINE
Uveal Melanoma
IDEAYA Biosciences
P3
BB
(66)
DACARBAZINE
Soft Tissue Sarcoma
Institut Bergonié
P3
BB
(66)
Dalzanemdor
Huntington Disease
Supernus Pharmaceuticals, Inc.
P3
BB
(66)
Showing 1076 to 1100 of 5,108 assets
Previous
Page 44 of 205
Next